mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.

Saved in:
Bibliographic Details
Title: mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.
Authors: Hosseini Kakroudi M; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran., Rezvanimehr A; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Zolfaghari K; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Baghaei-Shiva G; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Abbasi H; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Pourashory M; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Yazdanpanah N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran., Saleki K; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran., Rezaei N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@tums.ac.ir.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir.; Department of Immunology, Children's Medical Center Hospital, Tehran University of Medical Sciences, Dr. Qarib St, Keshavarz Blvd, Tehran, 14194, Iran. rezaei_nima@tums.ac.ir.
Source: Discover oncology [Discov Oncol] 2026 Apr 04; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 04.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41934551
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hosseini+Kakroudi+M%22">Hosseini Kakroudi M</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Rezvanimehr+A%22">Rezvanimehr A</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Zolfaghari+K%22">Zolfaghari K</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Baghaei-Shiva+G%22">Baghaei-Shiva G</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Abbasi+H%22">Abbasi H</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Pourashory+M%22">Pourashory M</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Yazdanpanah+N%22">Yazdanpanah N</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Saleki+K%22">Saleki K</searchLink>; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Rezaei+N%22">Rezaei N</searchLink>; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@tums.ac.ir.; Research Center for Immunodeficiencies, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir.; Department of Immunology, Children's Medical Center Hospital, Tehran University of Medical Sciences, Dr. Qarib St, Keshavarz Blvd, Tehran, 14194, Iran. rezaei_nima@tums.ac.ir.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101775142%22">Discover oncology</searchLink> [Discov Oncol] 2026 Apr 04; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Apr 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101775142 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-6011 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227306011%22">27306011 </searchLink><i>NLM ISO Abbreviation: </i>Discov Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41934551
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12672-026-04811-w
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: mRNA-based melanoma vaccines targeting gp100 and TRP2 macromolecules.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hosseini Kakroudi M
      – PersonEntity:
          Name:
            NameFull: Rezvanimehr A
      – PersonEntity:
          Name:
            NameFull: Zolfaghari K
      – PersonEntity:
          Name:
            NameFull: Baghaei-Shiva G
      – PersonEntity:
          Name:
            NameFull: Abbasi H
      – PersonEntity:
          Name:
            NameFull: Pourashory M
      – PersonEntity:
          Name:
            NameFull: Yazdanpanah N
      – PersonEntity:
          Name:
            NameFull: Saleki K
      – PersonEntity:
          Name:
            NameFull: Rezaei N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 04
              Text: 2026 Apr 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2730-6011
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Discover oncology
              Type: main
ResultId 1